![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1421-9786|22|1|57-60
ISSN: 1015-9770
Source: Cerebrovascular Diseases, Vol.22, Iss.1, 2006-04, pp. : 57-60
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antiplatelet Cilostazol Is Beneficial in Diabetic and/or Hypertensive Ischemic Stroke Patients
Cerebrovascular Diseases, Vol. 26, Iss. 1, 2008-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antiplatelet Drugs for Ischemic Stroke Prevention
Cerebrovascular Diseases, Vol. 27, Iss. 1, 2009-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antiplatelet Drugs in Ischemic Stroke Prevention: From Monotherapy to Combined Treatment
Cerebrovascular Diseases, Vol. 17, Iss. 1, 2003-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antiplatelet Agents for Stroke Prevention
Cerebrovascular Diseases, Vol. 10, Iss. 4, 2000-10 ,pp. :